Lupus patients find relief through online coaching program
NCT ID NCT06720584
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This completed study tested a health coach-led online program for 36 women with lupus. The program included 8 group sessions and 2 individual sessions to help participants set personal health goals and manage symptoms like fatigue, pain, and brain fog. Researchers measured satisfaction, attendance, and survey completion to see if the program was helpful and practical.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- health coach-led online support program
- What this could lead to
- If successful, this program could offer a practical way to improve daily life for people with lupus by helping them manage symptoms like fatigue and brain fog.
- What could go wrong
- This was a small, completed study with only 36 participants, so results may not apply to everyone. It tested a support program, not a medical treatment, so it won't change the disease itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke University
Durham, North Carolina, 27710, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Three-Drug combo quiet lupus kidney flares?
- Can a new antibody tame lupus flares?
- Can a single infusion of reprogrammed immune cells quiet lupus kidney disease?
- Eye tests could spot silent vision damage in lupus patients
- Could a simple blood test predict lupus in children with ITP?
- Can an extra shot boost COVID protection in autoimmune patients?